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INTRODUCTION
Early gastric cancer (EGC) was defined in 1962 by
Japanese Research Society for Gastric Cancer as a
carcinoma limited to the mucosa or submucosa without
lymph node involvement 1. All gastric cancers that have
passed the muscle layer accompanied or unaccompanied
by metastasis to surrounding organs or other body parts
are classified as advanced gastric cancer (AGC).2
In the United States, gastric cancer is the number 9
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most frequent malignancy in men and number 15 in
women. The incidence of gastric cancer in 1985 was
11.9 cases for every 100,000 men and 5.3 in 100,000
women. While in 1993, 24,000 people in the United States
were expected to suffer from gastric cancer, 13,000 of
which to the point of death.3
Japan is known to be the country with the highest
incidence of gastric cancer in the world,4 gastric cancer
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being the number one cause of death in the nation.3 The
incidence of gastric cancer in Japan is 84 for every
100,000 men.3 Other countries, such as Costa Rica,
Columbia, Singapore, and Iceland are also countries with
a high incidence of gastric cancer. Sujono Hadi reported
data from Indonesia demonstrating a relatively low
incidence rate in indigenous Indonesians (± 1-2%), but
an approximately 19% incidence rate in those of
Chinese decent.2
Data specific for early gastric cancer reported by the
Birmingham Cancer Registry from a registry of 13,228
cases of gastric cancer during the years 1960 to 1969 men-
tioned an incidence rate of 0.7%.5 In Japan, as a nation that
pays a great deal of attention to early gastric cancer,
developments in technology and diagnostic methods were
able to detect almost 10,000 cases of early gastric cancer
annually, which consists of 40-50% of all gastric cancers
(quoted from 1). In Indonesia, the  incidence rate for early
gastric cancer in 1980 is 2.2% in Jakarta, 1.7% in Medan,
and 1.4% in Surabaya. Data for years 1981 to 1987 in
Surabaya demonstrates an early gastric cancer of 9.1% of
all 186 cases of gastric cancers.6
Because most patients come with symptoms
associated with the gastrointestinal system, particularly
dyspepsia, early investigations of dyspepsia symptoms
should increase the detection of early gastric cancer.5
PATHOGENESIS
The etiology of gastric cancer is still unclear.
However, several observations that has been conducted
may be used to explain the pathogenesis:2
1. Abnormal mucosal changes
2. Epidemiological observations
3. Changes in various components
ABNORMAL MUCOSAL CHANGES
Hurst (1929) and Konjetzky (1936) were the first to
investigate the presence of abnormal mucosal changes
that often cause the development of gastric cancer.
Another common abnormality is atrophic gastritis that is
often accompanied by achlorhydria or hypochlorhydria.
It has also been mentioned that gastric cancer would not
occur in normal gastric mucosa.
Several benign changes in the gastric mucosa, such
as ulcer, polyp, and pernicious anemia that often occurs
at various levels of atrophic gastritis are pre-
carcinogenic factors.2 It has been mentioned that 3% of
ventricular ulcers will undergo malignant changes, while
5-10% of pernicious anemia has a risk of turning into
gastric cancer. While in gastric polyp, our attention is
more focused on villous adenoma, since reports of its
potential rate for turning malignant is 69%.3
EPIDEMIOLOGICAL OBSERVATION
Environmental conditions, life style, age, sex, genetic
factors, and race may play roles as risk factors for the
development of gastric cancer.
a. Age: The incidence of gastric cancer increases
progressively after the age of 35 to 85 years (1 per
100,000 to 96.1 per 100,000).3
b. Sex: The risk for the development of gastric cancer
worldwide is higher in men than in women, ranging
from 1.7 (Iran) to 9 (South Africa) times higher.3
c. Race: African Americans have a 3 times higher risk
for gastric cancer than white Americans.3 In
countries such as Chile, Japan, Iceland, Finland,
Austria, Russia, and Scandinavia, the frequency for
gastric cancer is very high compared to in other
countries.1 Studies report that Japanese who have
lived a long time in the United States have a lower
incidence rate of gastric cancer than those living in
their country. We can thus conclude that life style
plays an important role.7,8
d. Genetic factors:
• Familial history: a study of family history found
that gastric cancer is associated with a 2-3 times
increased risk in first generations.3
• Blood type: A blood type or specific substance
of the Lewis group has a 15-20% risk of
suffering from gastric cancer.3
• Familial syndrome: Peutz-Jeghers Syndrome
(multiple GI hamartomas polyps, melanic
pigmentation) that is autosomal dominantly
inherited has been mentioned to increase risks
of gastric cancer, but only in cases of gastric
hamartoma.3
• Hereditary autosomal dominant mutation of the
E-cadherin (CDH1) gene has been found in
families with diffuse gastric cancer. Hereditary
diffuse gastric cancer is an early gastric cancer
that develops at a young age.9
e. Diet: Welvaart and Zwaveling (1981) reported a clear
correlation between diet and gastric cancer. Smoked
and roasted meat that is often eaten in countries with
a high incidence rate of gastric cancer. Excessive
sodium intake and the use of preserved foods is
commonly found in countries with a high incidence
rate of gastric cancer.8
A substance that has received great attention is the
N-nitrose compound substance that is formed in foods
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that contain nitrates (smoked, slated, and acidified foods).
In the gaster, nitrates are changed into nitrites that then
undergo secondary or tertiary reaction to form
nitrosamine substances that are carcinogenic. A better
freezing system has reduced the need for nitrates, thus
reducing the risk for gastric cancer. Fresh fruits and
vegetables, especially those containing vitamin A and C,
inhibits the transformation of nitrates into nitrosamines.3,6
Full cream milk also reduces the risk of gastric cancer.6
HELYCOBACTER PYLORI AND GASTRIC CANCER
Data from the United States and Europe demonstrates
that the presence of H. pylori infection (Hp) increases
the risks for gastric cancer up to 6 times, and is found in
almost 50% cases of gastric cancer. The mechanism
that supports this is that chronic inflammation due to Hp
infection causes atrophic gastritis with reduced gastric
acid and secondary increase of the number of bacteria
that produces the nitrosamine carcinogen from a nitrate
diet. The most recent study by Kuipers et al in Hp
infected patients treated with proton-pump inhibitors dem-
onstrate an increased risk for atrophic gastritis compared
to those that underwent anti-reflux surgery. Thus,
gastric cancer increases with the more dispersed use of
this drug. In the United States, the risk rate for gastric
cancer from asymptomatic Hp infected individuals is low
(less than 1%).10
In the mean time, in an Asia-Pacific consensus
conference on the treatment of Hp infection in 1997 in
Singapore released several statements on the
correlation between Hp infection and gastric cancer:11
• Hp infection is a risk factor for gastric cancer in the
people of Asia.
• Recently, it has been found that there is no proof
that the eradication of Hp infection cures atrophic
gastritis and/or intestinal metaplasia.
• There is no sufficiently strong proof that eradication
of Hp infection reduces the risks or prevents the
development of gastric cancer.
• Hp infection is not a risk factor for gastric cancer in
the cardiac region.
• In Asia and the Pacific, the prevalence of cagA
positive Hp infection is very high, but it is useless to
use as a marker for the development of gastric   can-
cer. This is on the contrary to findings in Europe and
North America, where a strong correlation   between
gastric cancer and cagA positive Hp was found.
• There is no proof that early gastric disease in Asia is
a different disease entity.
• There is now recent proof that screening for
individuals with asymptomatic Hp infection and
successful treatment reduces the incidence of
gastric cancer.
HISTOPATHOLOGY
Approximately 3% of all operated benign ulcers are
associated with carcinoma of the mucosa, both near and
far from the ulcer. Findings of early gastric disease take
the form of rough mucosa with mildly pressed mucosal
folds, sometimes with protruding borders or image
similar to coral stones in the mucosa, but very well
covered that it is often passes unsuspected.7 The
carcinoma rarely spreads to lymph nodes. The reported
rate is 0-3%, for carcinoma of the mucosa, and 9-19%
for carcinoma of the submucosa.1
Lauren (1965) classified the histology of early
gastric cancer into 2 types, the intestinal and diffuse
infiltration types. The intestinal type is characterized by
an atypical tubular structure layered with bacillary,
disorganized thoracic epithelial cells with enlarged,
hyperchromatic or vesicular nuclei and a granular
cytoplasm. In the diffusely infiltrative type, the shape
and differentiation of the cells vary, from polygonal, round,
foam cells with vacuolar cytoplasm, or signet rings, spread
sporadically or clustered into small groups or in
a chord-like shape, spread out in the gastric mucosa.
Hirayama classified the intestinal type as well-
differentiated, and the diffusely infiltrative type as
undifferentiated.12
Biopsy in the area around the peptic ulcer may
demonstrate pre-cancerous changes in the form of
dysplasia. Dysplasia of gastric epithelial cells is
a pre-invasive lesion with increased carcinomatous
evolution in line with the degree of histological changes.13
It is difficult to differentiate dysplasia and reactive
epithelial atypia, and there have been proof that pure
dysplasia may be a predisposition for gastric cancer, which
can be detected in the early stages with multiple biopsy
regimens and close observation. A combination of
endoscopic biopsy and the brushing method for
cytological evaluation increases the sensitivity rate of
the diagnosis.7
CLASSIFICATION
Based the on findings from gastroscopy, fluoroscopy,
histopathology, and microscopic examination, endoscopic
experts from Japan from the Japanese
Research Society for Gastric Cancer in 1962, early
gastric cancer is classified into several types as follows:2,7
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Type I.  Protruded Type
• polypoid carcinoma similar to Borrman I
• invasion of carcinoma cells only limited to the
mucosa and submucosa
• irregular shape, irregular surface, bleeding
• with or without surface ulceration
Type II. Superficial Type
Classified into 3 subtypes:
IIa. Elevated Type
• little elevation of the gastric mucosa
• almost alike with type I but more widely distributed
and spread out
IIb. Flat Type
• no elevations or depression is found on the mucosa
• no mucosal color change
IIc.  Depressed Type
• irregular border and surface
• clubbing or nick of mucosa folds
• hyperemic or hemorrhagic border
• adherent mucous with a dirty layer
• island-like residue
Type III. Excavated Type
• carcinomatose ulcer similar to Borrman II
A patient may suffer from 2 or more early gastric
cancers, such as IIc + III or III + IIc, IIa + IIc, IIa + IIb
+ III, etc., where the first Roman numeral is more domi-
nant than the one that follows.
DIAGNOSIS
The diagnosis of gastric cancer is made from
physical examination, stool blood smear with the
Benzidine test, cytological evaluation, double contrast
X-ray, gastroscopy, gastrobiopsy, and radioactive
phosphor.2
There are no specific tumor markers for early
gastric cancer.6 The first clues are obtained from
endoscopic biopsy results demonstrating malignant cells.
The endoscopic image of the gaster may seem normal,
but most demonstrate a rough coral-like mucosa.
Gastric biopsy can easily detect diffuse carcinomatous
changes.7
Endoscopic evaluation of patients over 45 years of
age with new symptoms of dyspepsia can increase the
detection of early gastric cancer to 26%, and increase
the number of operable patients to 63%.14 According to
Thomas, there might be adequate consideration to
perform endoscopy on patients over 45 years of age prior
to medication. Even though there is yet sufficient proof
for this, this may be one of the means for early
detection.15
DYE-SPRAYING TECHNIQUES
In Japan, early gastric cancer detection is performed
using this technique, where the gastric mucosa is sprayed
with methylene blue during endoscopy. The dye colors
the intestinal mucosa but does not affect normal
mucosa, while cancerous tissue is not colored. This
technique is not used in the West.7
EARLY DETECTION
Early detection of early gastric cancer in Japan has
made great developments. Endoscopy experts in the
United States often discuss reports from Japan on early
gastric cancer.7
Careful gastric cytological evaluation has been proven
to be useful in the 1950s to 1960s for the early gastric
cancer detection. In Japan, they conducted screening
for the detection of early gastric cancer through mass
surveys. The protocol is open, where everyone 40-50
years of age with new symptoms of dyspepsia has to
undergo endoscopy, biopsy, and upper gastrointestinal
tract X-ray. Special attention is paid to patients with type
III intestinal dyspepsia. However, such early detection
is not performed in Europe and the United States due to
a difference in the health insurance system and based
on the consideration of a low incidence rate for early
gastric cancer.3,4 Such early detection has increased the
rate of diagnosis from 3% to 34.5%.3
 
 
Figure 1. Scheme for Macroscopic Types of Early Gastric Cancer2,12
CLINICAL FINDINGS
Patients with early gastric cancer are detected
clinically, since they come with recent dyspepsia or with
unrelenting gastric ulcer. Even though symptoms like
those of peptic ulcer have been heard for 20 years in
several patients, weight loss might be a different signal,
where clinical history do not point to carcinoma.7
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ENDOSCOPIC ULTRASONOGRAPHY (EUS)
For now, EUS is still the most accurate device to
establish the stage of early gastric cancer, particularly
for non-ulcerative lesions.16 If both EUS and
conventional endoscopy is performed to determine the
stage of early gastric cancer invasion, the accuracy of
the degree of the lesion is increased, reducing the
shortcomings of conventional endoscopy in determining
the stage of early gastric cancer, particularly in the
gastric corpus. As a comparison, the accuracy rate for
conventional endoscopy and EUS according to a study
by Hideo Yanai et al are 72.2% and 64.8%
respectively.17,18 Japan is a nation that has succeeded in
developing the device. There are several ultrasound
catheter probes that have been used in the development
of EMR in Japan, such as probes 7, 5, 12, 15 and 20
MHz. The accuracy rate for EUS is 20 MHz for
mucosal or submucosal staging of 72.3%, which can
provide imaging to the muscular mucosa. Nevertheless,
the efficacy of 20 MHz EUS has not been well agreed
upon in early gastric cancer.19
In EUS, the image of the normal gastric wall is
visualized as follows:17
• mucosa: a combination between the first hyperechoic
layer and the second hypoechoic layer
• submucosa: the third hyperechoic layer
• muscularis propia: the fourth hypoechoic layer
• serous and subserous: the fifth hyperechoic layer
Findings of early gastric cancer are interpreted by
determining tumor invasion according to the structure of
the four gastric walls, where lesions are classified as
EUS-M (mucosa), EUS-SM (submucosa), and EUS AD
(advanced).17
TREATMENT
Several literatures mention that the choice of
treatment for early gastric cancer is surgical treatment
or endoscopic mucosal resection. The most important
treatment procedure is to differentiate mucosal cancer
and tumor that has invaded to deeper submucous layer,
since this influences the choice of treatment, whether
endoscopy or surgery should be performed.17
If early gastric cancer is found in asymptomatic
patients with negative X-ray and endoscopic findings,
total gastrectomy should be considered, except when a
specific localized lesion is found.7
ENDOSCOPIC MUCOSAL RESECTION (EMR)
Endoscopic treatment is a local treatment indicated
for early gastric cancer without metastasis.19 EMR may
be an alternative treatment for patients who refuse
surgery or those who are bad candidates for surgery.20
The role and benefits of EMR are increased in the
treatment of early gastric cancer.18
Criteria for lesion that can be treated by means of
EMR are as follows: 18
1.  Elevation type of < 2 cm
2.  Depression type without ulceration < 1 cm
Successful treatment of early gastric cancer with
EMR usually has the following characteristics: 18
1. Is limited to the mucosa
2. Has a diameter of < 20 mm
3. There are no intramural ulcer changes
4. Is histologically classified as well-differentiated
adenocarcinoma
The EMR techniques that are used are as follows: 18
1. Double channel endoscopy
2. Aspiration mucosectomy and band ligation
For treatment, lesions are classified into 2 types:
1. Completely Resected (can undergo complete
resection): the vertical and horizontal cutoff lines are
not found following the first EMR.
2. Incompletely Resected (cannot undergo complete
resection): vertical and horizontal cutoff lines are
unclear following the first EMR.
Lesions that are incompletely resected may undergo
either laser therapy, EMR and laser therapy, ethanol
injection with heater probe coagulation, or heater probe
coagulation alone.1
The most common complication of EMR is bleeding,
which usually occurs in lesions over 30 mm in diameter.
Thus, EMR is not recommended in lesions over 30 mm
and for deep submucous infiltration. Perforation very
rarely occurs.18,20
Nevertheless, other imaging modalities are needed
to evaluate the extent of tissue involvement and the
presence of lymph node metastasis prior to
mucosectomy. EMR is a difficult and risky procedure.
Even though there have been many satisfying results of
many studies on EMR, in principle, an ideal technique
should be easy to use, easy to obtain, and effective.20
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy96
Gontar A. Siregar
PROGNOSIS
The prognosis for gastric cancer is not determined
by the microscopic classification of the type of cancer,
but most depends on the stage of invasion into the
gastric wall, metastasis to regional lymph nodes, and the
presence of distant metastasis.6
Early gastric cancer has a longer doubling time
compared to its metastasis and advanced gastric
cancer. For example, the doubling time of early gastric
cancer in Japan is reported to range between 1.6 to 9.5
years, while that of advanced gastric cancer ranges from
69 to 305 days with a 17.7 to 60.2 days range for tumor
metastasis to the abdominal wall.7 By establishing the
diagnosis of early gastric cancer, the prognosis is
generally better, since rapid treatment measures can be
taken.2 Patients with positive cytological results without
a detectable microscopic lesion is said to be able to
survive without treatment for 5 to 6 years before the
development of advanced lesions.7 Histopathologically,
the intestinal type early gastric cancer has a better
prognosis compared to the diffuse infiltrative type.12
The survival rate reported by the Birmingham
Cancer Registry for 1960-1969 in 90 patients with early
gastric cancer was 57.8%.5 Tsuhuma et al from the
Centre for Adult Disease reported a survival rate of 34
out of 56 observed cases of early gastric cancer that
has not undergone surgical treatment (64.5%).21 While
the 5-year survival rate for patients that undergo early
gastric cancer is over 90%.3,7,22 While they concluded
that early diagnosis and treatment reduces the mortality
in gastric cancer.21,22
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